Seasonal Affective Disorder

• FDA approval · 2008-07-09
  FDA Approved: BUPROPION HYDROCHLORIDE XL — Supplemental Application (Actavis Pharma, Inc.)

  FDA approved a supplemental application for Bupropion Hydrochloride XL, resulting in modifications to labeling/indications for the product.

• CLINICAL_TRIALS trial_result · 2008-03-04
  Clinical Trial Update: Effects of Season on Melatonin Secretion in Healthy Men and Women and Patients With Seasonal Affective Disorder

  This clinical trial update investigates how seasons influence melatonin secretion in healthy men and women and in patients with Seasonal Aff…

• FDA approval · 2008-01-16
  FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)

  FDA granted supplemental approval for Amneal Pharmaceuticals of New York LLC's generic bupropion hydrochloride (ANDA076711). The document in…

• FDA approval · 2007-09-17
  FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)

  FDA approved Amneal's supplemental ANDA for generic bupropion hydrochloride, enabling marketing of a generic formulation.

• FDA label_change · 2007-08-02
  FDA Approved: WELLBUTRIN XL — Supplemental Application (Bausch Health US LLC)

  FDA approved a supplemental application for WELLBUTRIN XL, resulting in changes to the product labeling.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2007-06-13
  FDA Approved: BUPROPION HYDROCHLORIDE XL — Original Application (Actavis Pharma, Inc.)

  FDA approved Actavis Pharma's generic extended-release formulation of bupropion hydrochloride XL under an original ANDA, typically indicated…

• FDA approval · 2007-06-04
  FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Epic Pharma LLC)

  FDA approved a supplemental application for Bupropion Hydrochloride from Epic Pharma LLC, granting regulatory approval of this generic produ…

• FDA approval · 2007-05-01
  FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)

  FDA approved a supplemental application for Bupropion hydrochloride from Aurobindo Pharma Limited, authorizing the generic product under an …

• CLINICAL_TRIALS research · 2007-01-15
  Clinical Trial Update: Light-Emitting Diode (LED) Light for Seasonal Affective Disorder (SAD) Treatment [NA]

  Ongoing clinical trial evaluating LED light therapy for seasonal affective disorder; current status is unknown.

• FDA approval · 2006-12-15
  FDA Approved: BUPROPION HYDROCHLORIDE — Original Application (Amneal Pharmaceuticals of New York LLC)

  FDA approved an original ANDA for Bupropion hydrochloride from Amneal Pharmaceuticals of New York LLC, providing a generic version of the an…

• FDA approval · 2006-10-05
  FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (BluePoint Laboratories)

  FDA approved a supplemental application for Bupropion Hydrochloride generic product by BluePoint Laboratories under an ANDA, updating the ap…

• FDA approval · 2006-10-05
  FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)

  The FDA approved Amneal Pharmaceuticals of New York's supplemental application for a generic form of bupropion hydrochloride, authorizing it…